These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
168 related items for PubMed ID: 6423905
1. Postsynaptic striatal dopamine agonist or antagonist actions of (+) or (-) 3-PPP and modification after receptor deafferentation. Oberlander C, Boissier JR. J Pharmacol; 1983; 14(4):401-4. PubMed ID: 6423905 [Abstract] [Full Text] [Related]
2. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine. Sindhu KM, Banerjee R, Senthilkumar KS, Saravanan KS, Raju BC, Rao JM, Mohanakumar KP. Pharmacol Biochem Behav; 2006 Jun; 84(2):321-9. PubMed ID: 16820197 [Abstract] [Full Text] [Related]
3. 7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist. Yasuda Y, Kikuchi T, Suzuki S, Tsutsui M, Yamada K, Hiyama T. Life Sci; 1988 Jun; 42(20):1941-54. PubMed ID: 3130534 [Abstract] [Full Text] [Related]
4. Relationship between receptor occupancy and response at striatal dopamine autoreceptors. Meller E, Bohmaker K, Namba Y, Friedhoff AJ, Goldstein M. Mol Pharmacol; 1987 Jun; 31(6):592-8. PubMed ID: 2885734 [Abstract] [Full Text] [Related]
9. The dopamine-gamma aminobutyric acid interaction in the striatum of the rat is differently regulated by dopamine D-1 and D-2 types of receptor: evidence obtained with rotational behavioural experiments. Herrera-Marschitz M, Ungerstedt U. Acta Physiol Scand; 1987 Mar; 129(3):371-80. PubMed ID: 3033996 [Abstract] [Full Text] [Related]
13. (+)- and (-)-3-PPP exhibit different intrinsic activity at striatal dopamine autoreceptors controlling dopamine synthesis. Clark D, Hjorth S, Carlsson A. Eur J Pharmacol; 1984 Oct 30; 106(1):185-9. PubMed ID: 6099268 [Abstract] [Full Text] [Related]
14. Increased behavioral response to dopaminergic stimulation of the subthalamic nucleus after nigrostriatal lesions. Mehta A, Thermos K, Chesselet MF. Synapse; 2000 Sep 15; 37(4):298-307. PubMed ID: 10891867 [Abstract] [Full Text] [Related]
15. Synaptic reorganisation in the rat striatum after dopaminergic deafferentation: an ultrastructural study using glutamate decarboxylase immunocytochemistry. Nitsch C, Riesenberg R. Synapse; 1995 Apr 15; 19(4):247-63. PubMed ID: 7792720 [Abstract] [Full Text] [Related]
16. Heterogeneous rotational responsiveness in 6-hydroxydopamine-denervated rats: pharmacological and neurochemical characterization. Liebman JM, Gerber R, Hall NR, Altar CA. Psychopharmacology (Berl); 1988 Apr 15; 96(4):477-83. PubMed ID: 3149769 [Abstract] [Full Text] [Related]
17. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats. Hossain MA, Weiner N. J Pharmacol Exp Ther; 1995 Oct 15; 275(1):237-44. PubMed ID: 7562556 [Abstract] [Full Text] [Related]